Frederic Ira Preffer, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flow Cytometry | 72 | 2023 | 6093 | 5.560 |
Why?
|
| Immunophenotyping | 18 | 2016 | 1894 | 1.110 |
Why?
|
| Hematopoietic Stem Cells | 10 | 2015 | 3394 | 0.990 |
Why?
|
| Hematologic Neoplasms | 11 | 2020 | 1688 | 0.800 |
Why?
|
| Lymphoma, T-Cell | 4 | 2018 | 298 | 0.790 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2013 | 4379 | 0.740 |
Why?
|
| Bone Marrow Transplantation | 15 | 2017 | 2766 | 0.690 |
Why?
|
| Blood Cells | 3 | 2014 | 318 | 0.620 |
Why?
|
| Antigens, Surface | 7 | 2015 | 1842 | 0.600 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 197 | 0.590 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 2015 | 380 | 0.560 |
Why?
|
| Plasma Cells | 3 | 2016 | 602 | 0.530 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2015 | 95 | 0.530 |
Why?
|
| Blood Platelets | 5 | 2014 | 2474 | 0.510 |
Why?
|
| Kidney Transplantation | 25 | 2017 | 4140 | 0.480 |
Why?
|
| Periodicals as Topic | 2 | 2017 | 1412 | 0.480 |
Why?
|
| Antigens, CD34 | 6 | 2011 | 664 | 0.460 |
Why?
|
| Monocytes | 5 | 2012 | 2620 | 0.450 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 2015 | 1487 | 0.450 |
Why?
|
| Transplantation Chimera | 12 | 2017 | 622 | 0.450 |
Why?
|
| Gold Colloid | 1 | 2011 | 17 | 0.440 |
Why?
|
| Stem Cells | 5 | 2015 | 3569 | 0.430 |
Why?
|
| Pancytopenia | 1 | 2012 | 105 | 0.420 |
Why?
|
| B-Lymphocytes | 7 | 2017 | 4902 | 0.410 |
Why?
|
| Antigens, Neoplasm | 6 | 2018 | 1987 | 0.410 |
Why?
|
| Neoplasm, Residual | 1 | 2016 | 986 | 0.390 |
Why?
|
| Leukocyte Count | 3 | 2012 | 1660 | 0.370 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 334 | 0.370 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2015 | 1897 | 0.360 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2022 | 2480 | 0.350 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2013 | 4262 | 0.340 |
Why?
|
| Multiple Myeloma | 6 | 2016 | 4969 | 0.340 |
Why?
|
| Transplantation Conditioning | 13 | 2014 | 1562 | 0.330 |
Why?
|
| Lymphoma | 8 | 2022 | 1881 | 0.330 |
Why?
|
| Antigens, CD | 12 | 2011 | 4152 | 0.320 |
Why?
|
| Bone Marrow | 5 | 2014 | 2926 | 0.310 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1514 | 0.310 |
Why?
|
| Antibodies, Monoclonal | 25 | 2010 | 9549 | 0.300 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2012 | 817 | 0.290 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2011 | 2546 | 0.280 |
Why?
|
| Transplantation Tolerance | 4 | 2017 | 614 | 0.280 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 6 | 2016 | 5113 | 0.260 |
Why?
|
| Graft Survival | 11 | 2017 | 3753 | 0.260 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2022 | 1017 | 0.250 |
Why?
|
| Bleomycin | 2 | 2004 | 504 | 0.250 |
Why?
|
| Mast Cells | 1 | 2011 | 1596 | 0.240 |
Why?
|
| T-Lymphocytes | 21 | 2020 | 10284 | 0.240 |
Why?
|
| Burkitt Lymphoma | 3 | 2013 | 364 | 0.240 |
Why?
|
| Hematopoiesis | 4 | 2014 | 1994 | 0.240 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2012 | 1252 | 0.230 |
Why?
|
| Antigens, CD20 | 7 | 2013 | 210 | 0.230 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2011 | 2647 | 0.230 |
Why?
|
| Humans | 127 | 2023 | 715818 | 0.220 |
Why?
|
| Antigens, CD19 | 4 | 2022 | 346 | 0.220 |
Why?
|
| Anti-Mullerian Hormone | 6 | 2012 | 389 | 0.220 |
Why?
|
| DNA, Neoplasm | 12 | 1996 | 1773 | 0.210 |
Why?
|
| Cell Differentiation | 12 | 2015 | 11655 | 0.210 |
Why?
|
| Malaria, Falciparum | 1 | 2009 | 953 | 0.210 |
Why?
|
| Immunization, Passive | 8 | 2003 | 630 | 0.200 |
Why?
|
| Immune Tolerance | 5 | 2017 | 2313 | 0.200 |
Why?
|
| Leukemia | 3 | 2011 | 1514 | 0.200 |
Why?
|
| Bone Marrow Cells | 5 | 2015 | 2562 | 0.190 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 675 | 0.190 |
Why?
|
| Killer Cells, Natural | 6 | 2018 | 2170 | 0.190 |
Why?
|
| Pulmonary Fibrosis | 1 | 2004 | 536 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2019 | 3268 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 7 | 2010 | 1659 | 0.180 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1203 | 0.170 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10615 | 0.170 |
Why?
|
| Transplantation, Homologous | 18 | 2014 | 4825 | 0.160 |
Why?
|
| Mycoplasma fermentans | 1 | 1997 | 9 | 0.160 |
Why?
|
| Staining and Labeling | 2 | 2012 | 1144 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2004 | 1893 | 0.160 |
Why?
|
| Myometrium | 2 | 2009 | 182 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2013 | 987 | 0.160 |
Why?
|
| Testicular Hormones | 4 | 2006 | 191 | 0.160 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2014 | 427 | 0.160 |
Why?
|
| Tonsillar Neoplasms | 1 | 2017 | 54 | 0.150 |
Why?
|
| Muromonab-CD3 | 2 | 1999 | 107 | 0.150 |
Why?
|
| Palatine Tonsil | 1 | 2017 | 193 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2013 | 1369 | 0.150 |
Why?
|
| Cell Lineage | 4 | 2014 | 2594 | 0.150 |
Why?
|
| Lectins | 2 | 2003 | 560 | 0.140 |
Why?
|
| Cobalt | 1 | 2016 | 161 | 0.140 |
Why?
|
| Cell Cycle | 6 | 2018 | 2991 | 0.140 |
Why?
|
| Orbital Pseudotumor | 1 | 2015 | 45 | 0.140 |
Why?
|
| Bacterial Adhesion | 1 | 1997 | 325 | 0.140 |
Why?
|
| Lymphocyte Count | 3 | 2017 | 808 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 2807 | 0.140 |
Why?
|
| Dacryocystitis | 1 | 2015 | 65 | 0.140 |
Why?
|
| Interleukin-2 | 10 | 2003 | 1923 | 0.130 |
Why?
|
| Peroxidase | 1 | 1998 | 629 | 0.130 |
Why?
|
| Dendritic Cells | 6 | 2003 | 2699 | 0.130 |
Why?
|
| Pneumonia | 2 | 2004 | 2099 | 0.130 |
Why?
|
| Animals | 48 | 2018 | 169404 | 0.130 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 1989 | 1016 | 0.130 |
Why?
|
| Antineoplastic Agents | 10 | 2016 | 13626 | 0.130 |
Why?
|
| Graft Rejection | 16 | 2011 | 4396 | 0.120 |
Why?
|
| Cell Separation | 7 | 2009 | 1817 | 0.120 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2022 | 868 | 0.120 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2013 | 1293 | 0.120 |
Why?
|
| Swine, Miniature | 1 | 2015 | 955 | 0.120 |
Why?
|
| Ovarian Neoplasms | 6 | 2012 | 4751 | 0.120 |
Why?
|
| Mice | 30 | 2018 | 80373 | 0.120 |
Why?
|
| Glycoproteins | 5 | 2006 | 2306 | 0.120 |
Why?
|
| Leukotriene B4 | 1 | 2014 | 317 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 2 | 2012 | 1373 | 0.120 |
Why?
|
| Cells, Cultured | 17 | 2015 | 19905 | 0.110 |
Why?
|
| Lymphocytes | 8 | 2004 | 2737 | 0.110 |
Why?
|
| Stem Cell Factor | 1 | 2012 | 222 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2012 | 11236 | 0.110 |
Why?
|
| Teriparatide | 1 | 2014 | 224 | 0.110 |
Why?
|
| Rare Diseases | 1 | 2017 | 530 | 0.110 |
Why?
|
| Bromodeoxyuridine | 4 | 2008 | 340 | 0.110 |
Why?
|
| Capillary Leak Syndrome | 1 | 2011 | 32 | 0.110 |
Why?
|
| Lymphoma, B-Cell | 1 | 2018 | 931 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 3 | 2010 | 2547 | 0.100 |
Why?
|
| Lung | 6 | 2004 | 9739 | 0.100 |
Why?
|
| Lymphocyte Transfusion | 3 | 2008 | 239 | 0.100 |
Why?
|
| Leukocytosis | 1 | 2012 | 248 | 0.100 |
Why?
|
| Fluorescent Dyes | 5 | 2012 | 1974 | 0.100 |
Why?
|
| Casein Kinase Ialpha | 1 | 2010 | 25 | 0.100 |
Why?
|
| Receptors, Peptide | 3 | 2007 | 268 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2012 | 1575 | 0.100 |
Why?
|
| Indicators and Reagents | 1 | 2011 | 477 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2017 | 3045 | 0.100 |
Why?
|
| Phycoerythrin | 1 | 2009 | 9 | 0.100 |
Why?
|
| ABO Blood-Group System | 1 | 2012 | 361 | 0.100 |
Why?
|
| Health Resources | 1 | 2016 | 926 | 0.100 |
Why?
|
| Immunologic Memory | 2 | 2017 | 1378 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2012 | 1390 | 0.090 |
Why?
|
| Hip Prosthesis | 1 | 2016 | 908 | 0.090 |
Why?
|
| Mastocytosis | 1 | 2011 | 151 | 0.090 |
Why?
|
| Waldenstrom Macroglobulinemia | 3 | 2005 | 1005 | 0.090 |
Why?
|
| Female | 51 | 2017 | 377229 | 0.090 |
Why?
|
| Macaca fascicularis | 9 | 2000 | 951 | 0.090 |
Why?
|
| Leiomyomatosis | 1 | 2009 | 72 | 0.090 |
Why?
|
| Immunoglobulin G | 5 | 2015 | 4492 | 0.090 |
Why?
|
| Colitis | 2 | 2012 | 1136 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 12305 | 0.090 |
Why?
|
| Immunosuppressive Agents | 9 | 2014 | 4193 | 0.090 |
Why?
|
| Cytodiagnosis | 1 | 2012 | 419 | 0.090 |
Why?
|
| Cell Division | 12 | 2009 | 4697 | 0.090 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2012 | 483 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2013 | 9730 | 0.090 |
Why?
|
| Kidney | 6 | 2014 | 6882 | 0.090 |
Why?
|
| Graft vs Tumor Effect | 1 | 2008 | 74 | 0.080 |
Why?
|
| Tunica Intima | 1 | 2010 | 482 | 0.080 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 3 | 2003 | 350 | 0.080 |
Why?
|
| Adipocytes | 2 | 2012 | 1173 | 0.080 |
Why?
|
| Antibody Specificity | 2 | 2009 | 1171 | 0.080 |
Why?
|
| Haplotypes | 3 | 2011 | 2885 | 0.080 |
Why?
|
| HIV Infections | 1 | 2013 | 15784 | 0.080 |
Why?
|
| Growth Inhibitors | 3 | 1999 | 384 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2009 | 551 | 0.080 |
Why?
|
| Platelet Count | 1 | 2010 | 795 | 0.080 |
Why?
|
| Male | 44 | 2017 | 350352 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2011 | 775 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2003 | 802 | 0.080 |
Why?
|
| Erythroid Cells | 1 | 2008 | 250 | 0.080 |
Why?
|
| Histocompatibility Testing | 5 | 2008 | 801 | 0.070 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2007 | 68 | 0.070 |
Why?
|
| Ploidies | 6 | 1996 | 282 | 0.070 |
Why?
|
| Chemokines, CC | 2 | 2004 | 287 | 0.070 |
Why?
|
| Vidarabine | 1 | 2007 | 348 | 0.070 |
Why?
|
| Stem Cell Transplantation | 2 | 2007 | 1639 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2012 | 995 | 0.070 |
Why?
|
| Conjunctival Neoplasms | 1 | 2007 | 85 | 0.070 |
Why?
|
| Cell Count | 4 | 2014 | 1912 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 4647 | 0.070 |
Why?
|
| Phenotype | 7 | 2017 | 16311 | 0.070 |
Why?
|
| Swine | 1 | 2015 | 5802 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4312 | 0.070 |
Why?
|
| Membrane Glycoproteins | 5 | 2005 | 3824 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2016 | 1362 | 0.070 |
Why?
|
| Isoenzymes | 3 | 2012 | 1803 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2004 | 843 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2012 | 2217 | 0.070 |
Why?
|
| Endothelium, Vascular | 3 | 2010 | 4586 | 0.070 |
Why?
|
| Postmenopause | 1 | 2014 | 2412 | 0.070 |
Why?
|
| Reference Values | 3 | 2010 | 5050 | 0.070 |
Why?
|
| Chorionic Gonadotropin | 1 | 2007 | 465 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 2729 | 0.070 |
Why?
|
| Eye Neoplasms | 1 | 2007 | 312 | 0.070 |
Why?
|
| Europe | 1 | 2011 | 3343 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 1754 | 0.070 |
Why?
|
| Orbital Neoplasms | 1 | 2007 | 238 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2014 | 2410 | 0.060 |
Why?
|
| Leukemia, T-Cell | 1 | 2004 | 110 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2993 | 0.060 |
Why?
|
| Megakaryocytes | 1 | 2008 | 533 | 0.060 |
Why?
|
| Mice, Knockout | 8 | 2014 | 15058 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2008 | 3636 | 0.060 |
Why?
|
| Immunohistochemistry | 8 | 2017 | 11689 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2100 | 0.060 |
Why?
|
| Prognosis | 10 | 2016 | 29007 | 0.060 |
Why?
|
| Ovary | 1 | 2008 | 1000 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2016 | 10503 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2014 | 2124 | 0.060 |
Why?
|
| Leukocytes | 2 | 2005 | 2092 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 447 | 0.060 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2002 | 66 | 0.060 |
Why?
|
| L-Selectin | 1 | 2003 | 225 | 0.060 |
Why?
|
| Radiation Tolerance | 2 | 1996 | 508 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2015 | 3579 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2014 | 3063 | 0.060 |
Why?
|
| Granulocytes | 1 | 2004 | 552 | 0.060 |
Why?
|
| Isoantibodies | 2 | 2017 | 666 | 0.060 |
Why?
|
| Genes, p53 | 2 | 1995 | 764 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1699 | 0.050 |
Why?
|
| Antibodies | 2 | 2009 | 2432 | 0.050 |
Why?
|
| Adult | 29 | 2017 | 212279 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2011 | 2153 | 0.050 |
Why?
|
| Middle Aged | 31 | 2017 | 214666 | 0.050 |
Why?
|
| Image Cytometry | 1 | 2001 | 50 | 0.050 |
Why?
|
| Tissue Transplantation | 1 | 2002 | 133 | 0.050 |
Why?
|
| Cell Movement | 4 | 2003 | 5397 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2002 | 263 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2003 | 329 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2003 | 325 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2010 | 14902 | 0.050 | |